You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GLP1 receptor agonists

Showing 1 - 25 of 8,251
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)

Terminated
  • Type 2 Diabetes
  • Exenatide Injection
  • Saline injection
  • Lancaster, Pennsylvania
    Amish Research Clinic
Mar 6, 2023

Diabetes Trial in Nanjing (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc)

Recruiting
  • Diabetes
  • Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
  • Nanjing, China
    Nanjing First Hospital, Nanjing Medical Univesity
Aug 6, 2023

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Aging, Diabetes, Type 2, PreDiabetes Trial in San Antonio (Semaglutide Injectable Product, Lifestyle Counseling)

Recruiting
  • Aging
  • +3 more
  • Semaglutide Injectable Product
  • Lifestyle Counseling
  • San Antonio, Texas
    UT Health San Antonio
Apr 3, 2023

Preoperative Prandial State of Patients Taking Glucagon-Like

Recruiting
  • Pulmonary Aspiration
  • Gastric ultrasound
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 6, 2023

Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

Recruiting
  • Osteoporosis, Postmenopausal
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Jackson, Mississippi
    University of Mississippi Medical Center
Aug 5, 2022

GLP-1 Receptor Agonists on Efficacy and Persistence, Adherence

Completed
  • Type 2 Diabetes
  • Obesity
  • Valencia, Spain
    INCLIVA
Sep 6, 2022

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS ,

Active, not recruiting
  • Weight Loss
  • +3 more
  • GLP-1 receptor agonist
  • Culleredo, A Coruña, Spain
  • +10 more
Jan 13, 2023

Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

Not yet recruiting
  • Morbid Obesity
  • +4 more
  • GLP-1 receptor agonist
  • Columbia, Missouri
    University of Missouri Hospital
Nov 20, 2023

Type 2 Diabetes Trial in Xuzhou (GLP-1 receptor agonist)

Recruiting
  • Type 2 Diabetes Mellitus
  • GLP-1 receptor agonist
  • Xuzhou, Jiangsu, China
    Department of Endocrinology
Apr 16, 2022

Based on Data From German Sick Funds That Looks at Costs of

Completed
  • Diabetes Mellitus, Type 2
  • Ingelheim am Rhein, Germany
    Boehringer Ingelheim
Jan 18, 2022

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

A Pan-European Post-Authorisation Safety Study: Risk of

Not yet recruiting
  • Pancreatic Cancer
  • Exenatide
  • Non-GLP-1 RA based glucose lowering drugs
  • (no location specified)
Dec 21, 2022

Anti-obesity Pharmacotherapy and Inflammation

Not yet recruiting
  • Obesity
  • Liraglutide or Semaglutide
  • Phentermine-Topiramate combination
  • New Orleans, Louisiana
  • +1 more
Mar 3, 2023

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Not yet recruiting
  • Gastric Ultrasound
  • +2 more
  • Gastric Ultrasound Exam
  • (no location specified)
Aug 15, 2023

Effects of GLP-1 Agonists on Gastric Volume

Not yet recruiting
  • Diabetes
  • +3 more
  • Gastric Ultrasound
  • Charleston, South Carolina
    Medical University of South Carolina
May 10, 2023

Delayed Gastric Emptying, Gastroparesis Trial in Chapel Hill (gastric ultrasound)

Not yet recruiting
  • Delayed Gastric Emptying
  • Gastroparesis
  • gastric ultrasound
  • Chapel Hill, North Carolina
    University of North Carolina Medical Center
Sep 8, 2023

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Type 1 Diabetes Trial (Semaglutide weekly injection)

Not yet recruiting
  • Type 1 Diabetes
  • Semaglutide weekly injection
  • (no location specified)
Sep 21, 2023

SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

Completed
  • Type 2 Diabetes
  • SGLT2 inhibitor
  • GLP-1 receptor agonist
  • Padova, Italy
    Division of Metabolic Diseases, University Hospital of Padova
Mar 8, 2020

Type II Diabetes Trial in Dijon (drug, procedure, other)

Recruiting
  • Type II Diabetes
  • GLP-1 agonists
  • +2 more
  • Dijon, France
    Chu Dijon Bourgogne
Jan 2, 2023

Obesity, Diabetes Type 2 Trial in Lancaster (Semaglutide Pen Injector [Ozempic])

Recruiting
  • Obesity
  • Diabetes Type 2
  • Semaglutide Pen Injector [Ozempic]
  • Lancaster, Pennsylvania
    Amish Research Clinic
Jul 29, 2022

HbA1c Among Type 2 Diabetes Newly Initiating GLP1RAs vs Basal

Unknown status
  • Diabetes Mellitus, Type 2
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 7, 2020